Dogwood Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.81

+0.06 (+3.14%)

As of Aug 9, 10:43 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +1,123.3% upside

Low Target $13.69

Average Target $22.08

High Target $22.84

Current Price $1.81

Current
$1.81

Target
$22.08

$13.69 $22.08 avg $22.84

Scenario Analysis

Bear Case

$13.69

658.4%

Low target

Base Case

$22.08

+1,123.3%

Avg target

Bull Case

$22.84

+1,165.4%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$9.50

-81.0% from high

52-Week Low

$1.28

+41.0% from low

Target vs 52W High

$22.08

+132.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%